Dr. Owen Ross is Co-PI for Project 1. Dr. Ross is an Associate Professor and Consultant within the Department of Neuroscience at the Mayo Clinic, and his main research focus is the genetics of Parkinsonism and related movement disorders. He has published over 200 articles on the genetics of aging and age-related neurodegenerative disease, and has received numerous foundation and federal grants, including NIH R01 funding focused on MAPT genetic variation in disease. Dr. Ross is also Director of the Genetic Core within the Mayo Clinic Udall Center of Excellence for Parkinson’s Disease Research. His recent work includes the publication of the first genome-wide association study in the tauopathy corticobasal degeneration (CBD), as well as the identification of MAPT A152T as a risk factor for Lewy body dementia. Dr. Ross is also part of a number of on-going Next-Generation Sequencing consortia efforts for Parkinson’s disease (PD), PSP, and CBD.